Skip to main content
. 2014 Dec 30;6(11):8777–8787. doi: 10.18632/oncotarget.3209

Table 1. Expression of Rad51C variants in tumors.

S.No Variant-1 Variant-2 Variant-3
Tumors 18/38 (47%) 12/38 (32%) 14/38 (37%)
Variants expressed in FANCD2 foci negative tumors / Total negative tumors 2/12 (17%) 2/12 (17%) 1/12 (8%)
Variants expressed in FANCD2 foci positive tumors / Total tumors 16/26 (62%) 10/26 (39%) 13/26 (50%)
Fishers exact P value 0.01 0.26 0.027